Abiopharma

🔍 Lange Douglas A. (Executive)

Company: HAWKINS INC (HWKN)

Report Date: 2026-08-25

Detailed Transactions and Holdings:

• Acquired 910 shares of Common Stock at $118.7536 per share (Direct)
  Date: 2026-08-25 | Code: P | equity_swap_involved: 0 | shares_owned_after: 28,168.81 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: H | nature_of_ownership: By ESOP Trustee | shares_owned_after: 821.74
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-25 | Code: H | nature_of_ownership: By IRA | shares_owned_after: 941.21

Footnotes:

• F1: Reflects the weighted average price of 910 shares of common stock of Hawkins, Inc. purchased by the reporting person in multiple transactions on August 25, 2026 with purchase prices ranging from $118.61 to $118.84 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
• F2: Includes 5.1019 shares acquired on June 12, 2026 pursuant to the Issuer's dividend reinvestment plan and 107 shares acquired on June 30, 2026 pursuant to the Issuer's employee stock purchase plan.